IMRT with capecitabine in advanced pancreatic cancer. In regard to Passoni et al

Affiliations

Comment

Gang Ren et al. Int J Radiat Oncol Biol Phys. 2014.

. 2014 Jun 1;89(2):431.

doi: 10.1016/j.ijrobp.2014.02.004. Epub 2014 May 5.

¹ Department of Radiation Oncology, Chinese PLA Air General Hospital, Beijing, China.

No abstract available

Comment in

In reply to Ren et al.
Passoni P, Reni M, Cattaneo GM, Slim N, Cereda S. Passoni P, et al. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):431-2. doi: 10.1016/j.ijrobp.2014.02.003. Epub 2014 May 5. Int J Radiat Oncol Biol Phys. 2014. PMID: 24837892 No abstract available.

Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study.
Passoni P, Reni M, Cattaneo GM, Slim N, Cereda S, Balzano G, Castoldi R, Longobardi B, Bettinardi V, Gianolli L, Gusmini S, Staudacher C, Calandrino R, Di Muzio N. Passoni P, et al. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1000-6. doi: 10.1016/j.ijrobp.2013.09.012. Int J Radiat Oncol Biol Phys. 2013. PMID: 24267968 Clinical Trial.